πŸ‡ΊπŸ‡Έ FDA
Patent

US 10428025

Antifungal compound process

granted A61PA61P31/02A61P31/10

Quick answer

US patent 10428025 (Antifungal compound process) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P31/02, A61P31/10